Divi's Lab.

  • Market Cap: Large Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE361B01024
  • NSEID: DIVISLAB
  • BSEID: 532488
INR
6,642.15
-17.95 (-0.27%)
BSENSE

Jun 18

BSE+NSE Vol: 1.6 lacs

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy
Comparison
Company
Score
Quality
Valuation
Financial
Technical
Sun Pharma.Inds.
Biocon
Laurus Labs
Divi's Lab.
Dr Reddy's Labs
Torrent Pharma
Cipla
Zydus Lifesci.
Lupin
Mankind Pharma
Aurobindo Pharma
Why is Divis Laboratories Ltd ?
1
High Management Efficiency with a high ROE of 16.32%
2
Company has a low Debt to Equity ratio (avg) at 0 times
3
Poor long term growth as Net Sales has grown by an annual rate of 8.67% and Operating profit at 2.81% over the last 5 years
4
The company has declared Positive results for the last 7 consecutive quarters
  • NET SALES(Q) Highest at Rs 2,831.00 cr
  • PBDIT(Q) Highest at Rs 934.00 cr.
  • PBT LESS OI(Q) Highest at Rs 808.00 cr.
5
Stock is technically in a Bullish range
  • The technical trend has improved from Mildly Bullish on 16-Jun-26 and has generated -1.23% returns since then
  • Multiple factors for the stock are Bullish like MACD, Bollinger Band and KST
6
With ROE of 15.7, it has a Very Expensive valuation with a 10.5 Price to Book Value
  • The stock is trading at a premium compared to its peers' average historical valuations
  • Over the past year, while the stock has generated a return of 1.62%, its profits have risen by 19.7% ; the PEG ratio of the company is 3.4
7
High Institutional Holdings at 39.51%
  • These investors have better capability and resources to analyse fundamentals of companies than most retail investors.
stock-recommendationReal-Time Research Report
Verdict Report
How much should you hold?
  1. Overall Portfolio exposure to Divi's Lab. should be less than 10%
  2. Overall Portfolio exposure to Pharmaceuticals & Biotechnology should be less than 30%

(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)

When to exit? - We will constantly monitor the company and suggest at the appropriate time to exit from the stock

Is Divi's Lab. for you?

Medium Risk, Medium Return

Absolute
Risk Adjusted
Volatility
Divi's Lab.
1.56%
0.07
24.00%
Sensex
-5.12%
-0.38
13.26%
stock-recommendationQuality
stock-summaryManagement Risk
stock-summaryGrowth
stock-summaryCapital Structure
stock-recommendation
Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors
Factor
Value
Sales Growth (5y)
8.67%
EBIT Growth (5y)
2.81%
EBIT to Interest (avg)
100.00
Debt to EBITDA (avg)
Net Debt is too low
Net Debt to Equity (avg)
-0.20
Sales to Capital Employed (avg)
0.66
Tax Ratio
24.20%
Dividend Payout Ratio
36.28%
Pledged Shares
0
Institutional Holding
39.51%
ROCE (avg)
26.14%
ROE (avg)
16.32%
stock-recommendationValuation
Valuation Scorecard stock-summary
stock-recommendation
Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors stock-summary
Factor
Value
P/E Ratio
67
Industry P/E
34
Price to Book Value
10.55
EV to EBIT
58.23
EV to EBITDA
50.39
EV to Capital Employed
12.98
EV to Sales
16.42
PEG Ratio
3.42
Dividend Yield
0.45%
ROCE (Latest)
22.30%
ROE (Latest)
15.65%
Loading Valuation Snapshot...
stock-recommendationTechnicals
Technical key factors
Indicator
Weekly
Monthly
MACD
Bullish
Mildly Bearish
RSI
No Signal
No Signal
Bollinger Bands
Bullish
Mildly Bullish
Moving Averages
Bullish (Daily)
KST
Bullish
Mildly Bearish
Dow Theory
No Trend
Mildly Bullish
OBV
No Trend
Mildly Bullish
stock-recommendation Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
Technical Movement
stock-recommendationFinancial Trend
Financial Trend Scorecard stock-summary
stock-recommendation
Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

6What is working for the Company
NET SALES(Q)

Highest at Rs 2,831.00 cr

PBDIT(Q)

Highest at Rs 934.00 cr.

PBT LESS OI(Q)

Highest at Rs 808.00 cr.

PAT(Q)

Highest at Rs 751.00 cr.

EPS(Q)

Highest at Rs 28.34

0What is not working for the Company
NO KEY NEGATIVE TRIGGERS
Loading Valuation Snapshot...
Here's what is working for Divi's Lab.
Net Sales - Quarterly
Highest at Rs 2,831.00 cr
in the last five quarters
MOJO Watch
Near term sales trend is positive

Net Sales (Rs Cr)

Operating Profit (PBDIT) - Quarterly
Highest at Rs 934.00 cr.
in the last five quarters
MOJO Watch
Near term Operating Profit trend is positive

Operating Profit (Rs Cr)

Profit Before Tax less Other Income (PBT) - Quarterly
Highest at Rs 808.00 cr.
in the last five quarters
MOJO Watch
Near term PBT trend is positive

PBT less Other Income (Rs Cr)

Profit After Tax (PAT) - Quarterly
Highest at Rs 751.00 cr.
in the last five quarters
MOJO Watch
Near term PAT trend is positive

PAT (Rs Cr)

Earnings per Share (EPS) - Quarterly
Highest at Rs 28.34
in the last five quarters
MOJO Watch
Increasing profitability; company has created higher earnings for shareholders

EPS (Rs)

Here's what is not working for Divi's Lab.
Non Operating Income - Quarterly
Highest at Rs 155.00 cr
in the last five quarters
MOJO Watch
Increased income from non business activities may not be sustainable

Non Operating Income